1 day Ago By ABMN Staff
Tenet Healthcare Co. ( NYSE:THC – Get Free Report ) has been given a consensus rating of “Buy” by the seventeen ratings firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company.
The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $152.69. THC has been the subject of a number of research reports.
Truist Financial reissued a “buy” rating and set a $170.00 price target (up previously from $155.00) on shares of Tenet Healthcare in a research report on Thursday, July 25th.
Raymond James raised their price target on shares of Tenet Healthcare from $130.00 to $175.00 and gave the company a “strong-buy” rating in a report on Thursday, July 25th.
Cantor Fitzgerald reissued an “overweight” rating and issued a $168.00 price objective on shares of Tenet Healthcare in a research report on Monday, August 19th. UBS Group lifted their target price on shares of Tenet Healthcare from $180.
00 to $197.00 and gave the company a “buy” rating in a report on Wednesday, August 14th. Finally, Robert W.
Baird initiated coverage on Tenet Healthcare in a research report on Thursday, May 30th. They issued an “outperform” rating and a $153.00 price objective on the stock.
Get Our Latest Analysis on Tenet Healthcare Tenet Healthcare Stock Up 2.7 % Tenet Healthcare ( NYSE:THC – Get Free Report ) last released its earnings results on Wednesday, July 24th. The company reported $2.
31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.89 by $0.42.
The firm had revenue of $5.10 billion during the quarter, compared to the consensus estimate of $4.98 billion.
Tenet Healthcare had a net margin of 13.17% and a return on equity of 24.66%.
On average, research analysts forecast that Tenet Healthcare will post 10.7 EPS for the current year. Tenet Healthcare announced that its board has authorized a stock buyback program on Wednesday, July 24th that authorizes the company to repurchase $1.
50 billion in shares. This repurchase authorization authorizes the company to reacquire up to 10.3% of its shares through open market purchases.
Shares repurchase programs are often a sign that the company’s board believes its shares are undervalued. Insider Transactions at Tenet Healthcare In other Tenet Healthcare news, Director Meghan Fitzgerald sold 20,000 shares of the stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $146.
34, for a total transaction of $2,926,800.00. Following the transaction, the director now owns 15,269 shares of the company’s stock, valued at approximately $2,234,465.
46. The transaction was disclosed in a document filed with the SEC, which is available at this link . In other Tenet Healthcare news, Director Meghan Fitzgerald sold 20,000 shares of the business’s stock in a transaction on Tuesday, August 6th.
The shares were sold at an average price of $146.34, for a total transaction of $2,926,800.00.
Following the completion of the sale, the director now owns 15,269 shares in the company, valued at $2,234,465.46. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website .
Also, CEO Saumya Sutaria sold 86,227 shares of Tenet Healthcare stock in a transaction dated Wednesday, August 14th. The shares were sold at an average price of $154.41, for a total transaction of $13,314,311.
07. Following the completion of the transaction, the chief executive officer now directly owns 13,773 shares of the company’s stock, valued at $2,126,688.93.
The disclosure for this sale can be found here . Over the last 90 days, insiders have sold 128,203 shares of company stock valued at $19,754,997. Insiders own 0.
93% of the company’s stock. Institutional Trading of Tenet Healthcare Several hedge funds have recently bought and sold shares of the company. Sanctuary Advisors LLC acquired a new stake in shares of Tenet Healthcare in the second quarter valued at approximately $357,000.
Ariadne Wealth Management LP acquired a new stake in Tenet Healthcare in the 2nd quarter valued at approximately $85,000. Cetera Investment Advisers boosted its position in Tenet Healthcare by 20.4% during the 2nd quarter.
Cetera Investment Advisers now owns 20,295 shares of the company’s stock worth $2,700,000 after acquiring an additional 3,439 shares during the period. Truist Financial Corp raised its stake in shares of Tenet Healthcare by 155.2% during the second quarter.
Truist Financial Corp now owns 24,175 shares of the company’s stock valued at $3,216,000 after purchasing an additional 14,703 shares in the last quarter. Finally, Quarry LP lifted its holdings in Tenet Healthcare by 37.3% in the second quarter.
Quarry LP now owns 626 shares of the company’s stock worth $83,000 after purchasing an additional 170 shares during the period. 95.44% of the stock is currently owned by institutional investors.
About Tenet Healthcare ( Get Free Report Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Stories Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter ..
